Download Citation
Article Source:
C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patients
Patil NS,
Zou W,
Mocci S,
Sandler A,
Ballinger M,
et al.
(2021)
C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patients.
PLOS ONE 16(2): e0246486.
https://doi.org/10.1371/journal.pone.0246486